DEVELOPMENT OF BIOCOMPONENTS FROM NATURAL SOURCES AND LABORATORY PRODUCT FOR VARICOSE AND DIABETIC WOUNDS (Q3831794): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Created claim: summary (P836): Alex 1977 Ltd. is an innovative company established in 2011 with the main subject of scientific, research and development (R & D), for which in 2017 it received the award “Pythagoras 2016” for a company with the most funds for R & D. The team of the company has a great scientific experience in creating innovative products realised on the international market. The main objective of the project proposal is the development of PRODUCT innovation, a...) |
||||||||||||||
| Property / summary | |||||||||||||||
Alex 1977 Ltd. is an innovative company established in 2011 with the main subject of scientific, research and development (R & D), for which in 2017 it received the award “Pythagoras 2016” for a company with the most funds for R & D. The team of the company has a great scientific experience in creating innovative products realised on the international market. The main objective of the project proposal is the development of PRODUCT innovation, a novelty of WORLD importance to reach TRL6 technological readiness. PRODUCT innovation is a laboratory model of gel for varicose and diabetic wounds (LOGVDR), designed for the needs of many people and corresponds to Objective 1 of “Bio-technology with direct application for healthy lifestyle”. the formation of a highly qualified team as well as external services are necessary for the development of innovative biotechnology for isolation and research of active ingredients from snails Helix aspersa, plantain (Plantago major), calendula officinalis, hydrolysates from collagen, DNA and RNA, and addition of copper ions. Another important goal is the development of environmentally friendly technologies for obtaining extracts and combining them in LAGVDR to achieve a wide range of action. An innovative method of application to LOGVDR wounds in combination with laser therapy will be developed. This will stimulate the penetration of active substances, regeneration of cells and breakdown of necrotic tissue, which will have a healing and preventive effect for suppressing the inflammatory processes of the wall of the veins and protecting the capillaries and blood vessels. As a result of the implementation of the project is expected: •Provision of laboratory technology and laboratory sample gel for the therapy of varicose and diabetic wounds, which are a pandemic of our modern times and in case of improper treatment ends with amputation of the limbs. •Increasing the competitiveness of the company on the Bulgarian and international market. (English) | |||||||||||||||
| Property / summary: Alex 1977 Ltd. is an innovative company established in 2011 with the main subject of scientific, research and development (R & D), for which in 2017 it received the award “Pythagoras 2016” for a company with the most funds for R & D. The team of the company has a great scientific experience in creating innovative products realised on the international market. The main objective of the project proposal is the development of PRODUCT innovation, a novelty of WORLD importance to reach TRL6 technological readiness. PRODUCT innovation is a laboratory model of gel for varicose and diabetic wounds (LOGVDR), designed for the needs of many people and corresponds to Objective 1 of “Bio-technology with direct application for healthy lifestyle”. the formation of a highly qualified team as well as external services are necessary for the development of innovative biotechnology for isolation and research of active ingredients from snails Helix aspersa, plantain (Plantago major), calendula officinalis, hydrolysates from collagen, DNA and RNA, and addition of copper ions. Another important goal is the development of environmentally friendly technologies for obtaining extracts and combining them in LAGVDR to achieve a wide range of action. An innovative method of application to LOGVDR wounds in combination with laser therapy will be developed. This will stimulate the penetration of active substances, regeneration of cells and breakdown of necrotic tissue, which will have a healing and preventive effect for suppressing the inflammatory processes of the wall of the veins and protecting the capillaries and blood vessels. As a result of the implementation of the project is expected: •Provision of laboratory technology and laboratory sample gel for the therapy of varicose and diabetic wounds, which are a pandemic of our modern times and in case of improper treatment ends with amputation of the limbs. •Increasing the competitiveness of the company on the Bulgarian and international market. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: Alex 1977 Ltd. is an innovative company established in 2011 with the main subject of scientific, research and development (R & D), for which in 2017 it received the award “Pythagoras 2016” for a company with the most funds for R & D. The team of the company has a great scientific experience in creating innovative products realised on the international market. The main objective of the project proposal is the development of PRODUCT innovation, a novelty of WORLD importance to reach TRL6 technological readiness. PRODUCT innovation is a laboratory model of gel for varicose and diabetic wounds (LOGVDR), designed for the needs of many people and corresponds to Objective 1 of “Bio-technology with direct application for healthy lifestyle”. the formation of a highly qualified team as well as external services are necessary for the development of innovative biotechnology for isolation and research of active ingredients from snails Helix aspersa, plantain (Plantago major), calendula officinalis, hydrolysates from collagen, DNA and RNA, and addition of copper ions. Another important goal is the development of environmentally friendly technologies for obtaining extracts and combining them in LAGVDR to achieve a wide range of action. An innovative method of application to LOGVDR wounds in combination with laser therapy will be developed. This will stimulate the penetration of active substances, regeneration of cells and breakdown of necrotic tissue, which will have a healing and preventive effect for suppressing the inflammatory processes of the wall of the veins and protecting the capillaries and blood vessels. As a result of the implementation of the project is expected: •Provision of laboratory technology and laboratory sample gel for the therapy of varicose and diabetic wounds, which are a pandemic of our modern times and in case of improper treatment ends with amputation of the limbs. •Increasing the competitiveness of the company on the Bulgarian and international market. (English) / qualifier | |||||||||||||||
point in time: 2 December 2021
| |||||||||||||||
Revision as of 11:12, 2 December 2021
Project Q3831794 in Bulgaria
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DEVELOPMENT OF BIOCOMPONENTS FROM NATURAL SOURCES AND LABORATORY PRODUCT FOR VARICOSE AND DIABETIC WOUNDS |
Project Q3831794 in Bulgaria |
Statements
191,221.1 Bulgarian lev
0 references
321,380.0 Bulgarian lev
0 references
0.59 percent
0 references
20 July 2018
0 references
13 November 2020
0 references
0 references
"Алекс 1977" ЕООД е иновативна компания, създадена през 2011 г. с основен предмет научна, изследователска и развойна дейност (НИРД), за което през 2017 г. получава награда "Питагор 2016" за фирма с най-много средства за НИРД. Екипът на дружеството е с голям научен опит в създаване на иновативни продукти, реализирани на международния пазара.Основната ЦЕЛ на проектното предложение е разработване на ПРОДУКТОВА иновация, новост от СВЕТОВНО значение, която да достигане до технологична готовност TRL6.ПРОДУКТОВАТА иновация представлява лабораторен образец на гел за варикозни и диабетни рани (ЛОГВДР), предназначен за нуждите на много хора и съответства на Цел 1 от «Био-технологии с пряко приложение за здравословен начин на живот».Заложеното закупуване на ДМА и ДНА, сформирането на висококвалифициран екип, както и външните услуги са необходими за разработване на иновативни биотехнологии за изолиране и изследване на активни съставки от охлюви Helix aspersa, живовляк (Plantago major), невен (Calendula officinalis), хидролизати от колаген, от ДНК и РНК, и добавяне на медни йони.Друга важна цел е разработване на екологично чисти технологии за получаване на екстракти и комбинирането им в ЛОГВДР, за постигане на широк спектър на действие.Ще бъде разработен иновативен метод за прилагане върху раните на ЛОГВДР, в комбинация с лазерна терапия. Това ще стимулира проникването на активните вещества, регенерирането на клетките и разпадане на некротичната тъкан, което ще има оздравителен и превантивен ефект за потискане на възпалителните процеси на стената на вените и предпазване на капилярите и кръвоносните съдове.Като резултат от изпълнението на проекта се очаква:•Предлагане на лабораторна технология и лабораторен образец на гел за терапия на варикозни и диабетни рани, които са пандемия на нашето съвремие и при неправилно лечение завършва с ампутация на крайниците.•Повишаване конкурентоспособността на дружеството на Българския и международния пазар. (Bulgarian)
0 references
Alex 1977 Ltd. is an innovative company established in 2011 with the main subject of scientific, research and development (R & D), for which in 2017 it received the award “Pythagoras 2016” for a company with the most funds for R & D. The team of the company has a great scientific experience in creating innovative products realised on the international market. The main objective of the project proposal is the development of PRODUCT innovation, a novelty of WORLD importance to reach TRL6 technological readiness. PRODUCT innovation is a laboratory model of gel for varicose and diabetic wounds (LOGVDR), designed for the needs of many people and corresponds to Objective 1 of “Bio-technology with direct application for healthy lifestyle”. the formation of a highly qualified team as well as external services are necessary for the development of innovative biotechnology for isolation and research of active ingredients from snails Helix aspersa, plantain (Plantago major), calendula officinalis, hydrolysates from collagen, DNA and RNA, and addition of copper ions. Another important goal is the development of environmentally friendly technologies for obtaining extracts and combining them in LAGVDR to achieve a wide range of action. An innovative method of application to LOGVDR wounds in combination with laser therapy will be developed. This will stimulate the penetration of active substances, regeneration of cells and breakdown of necrotic tissue, which will have a healing and preventive effect for suppressing the inflammatory processes of the wall of the veins and protecting the capillaries and blood vessels. As a result of the implementation of the project is expected: •Provision of laboratory technology and laboratory sample gel for the therapy of varicose and diabetic wounds, which are a pandemic of our modern times and in case of improper treatment ends with amputation of the limbs. •Increasing the competitiveness of the company on the Bulgarian and international market. (English)
2 December 2021
0 references
София
0 references
Identifiers
BG16RFOP002-1.005-0019
0 references